VATE INNOVATE CORP

INNOVATE Corp. to Report Fourth Quarter and Full Year 2023 Results on March 4th

INNOVATE Corp. to Report Fourth Quarter and Full Year 2023 Results on March 4th

NEW YORK, Feb. 12, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2023 on Monday, March 4, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.

Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at . To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the “Investor Relations” portion of the INNOVATE website.

Conference Call Details

Live Call

Domestic Dial-In: 1-888-886-7786

Toll/International: 1-416-764-8658

Conference Number: 25925635

Conference Replay*

Domestic Dial-In: 1-844-512-2921

Toll/International: 1-412-317-6671

Conference Number: 25925635

*Available approximately three hours after the end of the conference call through March 18, 2024.

About INNOVATE

INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit: .

Investor Contact:

Solebury Strategic Communications

Anthony Rozmus



(212) 235-2691



EN
12/02/2024

Underlying

VATEINNOVATE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INNOVATE CORP

 PRESS RELEASE
Free
VATE INNOVATE CORP

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

MediBeacon® Next Generation TGFR™ System Receives FDA Approval MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers begins in early 2026 NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% equity interest, has received...

December 16, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE Corp. Announces Third Quarter 2025 Results

INNOVATE Corp. Announces Third Quarter 2025 Results - Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China -- Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery - NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the third quarter.  Financial Summary (in millions, except per share amounts)Three Months...

November 12, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th

INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 12, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the...

October 22, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

MediBeacon receives regulatory approval to sell the Transdermal GFR Sy...

MediBeacon receives regulatory approval to sell the Transdermal GFR System in China MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for sale in China before the end of the year NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an e...

October 21, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend

INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $8.8 million, or $2.28 per share, on November 10, 2025 to DBMG’s stockholders of record at the close of business on October 27, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $8 million o...

October 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch